Last update 02 Apr 2026
Tibet Minzu University

Tibet Minzu University

Education|2017

Overview

Tags

Nervous System Diseases
Neoplasms
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Nervous System Diseases2
Neoplasms2
Immune System Diseases1
Infectious Diseases1
Top 5 Drug TypeCount
Small molecule drug3
Top 5 TargetCount
NF-κB(Nuclear factor NF-kappa-B complex)1
NF-κB x TGF-β21
GPX4 x MnSOD x Nrf2 x SIRT3 x SLC7A111

Related

3
Drugs associated with Tibet Minzu University
Salidroside
Target
NF-κB x TGF-β2
Mechanism
NF-κB inhibitors [+1]
Active Org.
Yanbian UniversityYanbian University [+3]
Originator Org.
Anhui Healstar Pharmaceutical Co., Ltd.Anhui Healstar Pharmaceutical Co., Ltd. [+1]
Active Indication
Alzheimer Disease [+4]
Inactive Indication
Coronary Artery Disease
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date-
Isochlorogenic Acid C
Target
GPX4 x MnSOD x Nrf2 x SIRT3 x SLC7A11
Mechanism
GPX4 modulators [+4]
Active Org.
University of FukuiUniversity of Fukui [+2]
Originator Org.
China University of Mining & TechnologyChina University of Mining & Technology
Active Indication
Neoplasms [+1]
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
Rosavin
Target
NF-κB
Mechanism
NF-κB inhibitors
Active Org.
Tibet Minzu UniversityTibet Minzu University
Originator Org.
Tibet Minzu UniversityTibet Minzu University
Active Indication
Alzheimer Disease
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Tibet Minzu University
ITMCTR2026000334
/ SuspendedNot ApplicableIIT
Mechanistic Study of Acupuncture-Mediated Neuroendocrine Regulation That Delays Ovarian Aging in Primary Ovarian Insufficiency Through the Brain–Ovary Axis
100 Clinical Results associated with Tibet Minzu University
Login to view more data
0 Patents (Medical) associated with Tibet Minzu University
Login to view more data
100 Deals associated with Tibet Minzu University
Login to view more data
100 Translational Medicine associated with Tibet Minzu University
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 12 Apr 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
3
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Rosavin
 ( NF-κB )		Alzheimer Disease
More
Preclinical
Salidroside
 ( NF-κB x TGF-β2 )		Alzheimer Disease
More
Preclinical
Isochlorogenic Acid C
 ( GPX4 x MnSOD x Nrf2 x SIRT3 x SLC7A11 )		Neoplasms
More
Preclinical
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free